Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial.
Cites articles 24
Date
Title
Article - wd:Q51910874
Article - wd:Q51910874